IT1115552B - Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno - Google Patents

Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno

Info

Publication number
IT1115552B
IT1115552B IT67468/77A IT6746877A IT1115552B IT 1115552 B IT1115552 B IT 1115552B IT 67468/77 A IT67468/77 A IT 67468/77A IT 6746877 A IT6746877 A IT 6746877A IT 1115552 B IT1115552 B IT 1115552B
Authority
IT
Italy
Prior art keywords
lipoproteins
plasma
procedure
blood serum
selective elimination
Prior art date
Application number
IT67468/77A
Other languages
English (en)
Original Assignee
New Zealand Dev Finance
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Dev Finance filed Critical New Zealand Dev Finance
Application granted granted Critical
Publication of IT1115552B publication Critical patent/IT1115552B/it

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16Organic material
    • B01J39/18Macromolecular compounds
    • B01J39/22Cellulose or wood; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00Ion-exchange processes in general; Apparatus therefor
    • B01J47/014Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Ecology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IT67468/77A 1976-03-04 1977-03-03 Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno IT1115552B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ180199A NZ180199A (en) 1976-03-04 1976-03-04 Method of testing for the presence of elevated plasma liprotein concentration

Publications (1)

Publication Number Publication Date
IT1115552B true IT1115552B (it) 1986-02-03

Family

ID=19917635

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67468/77A IT1115552B (it) 1976-03-04 1977-03-03 Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno

Country Status (9)

Country Link
US (1) US4096136A (it)
JP (1) JPS52125396A (it)
AU (1) AU2279777A (it)
DE (1) DE2708912C2 (it)
FR (1) FR2343251A1 (it)
GB (2) GB1543016A (it)
IT (1) IT1115552B (it)
NZ (1) NZ180199A (it)
SE (1) SE447873B (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5460996A (en) * 1977-10-22 1979-05-16 Mitsubishi Chem Ind Method of measuring amount of sugar
US4190628A (en) * 1977-11-21 1980-02-26 Trustees Of Boston University Kit for determining the level of LDL cholesterol in body fluids
DE2963844D1 (en) * 1978-07-04 1982-11-18 Goella Lab Method and reagents for measuring the cholesterol content in serum
US4188188A (en) * 1978-09-27 1980-02-12 Bio-Rad Laboratories, Inc. High density lipoprotein cholesterol assay
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4264471A (en) * 1979-06-04 1981-04-28 E. I. Du Pont De Nemours And Company Serum and plasma clarification process
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method
US4290774A (en) * 1980-01-07 1981-09-22 Miles Laboratories, Inc. Purification of lipoprotein cholesterol for use as a cholesterol reference material
DE3007764A1 (de) * 1980-02-29 1981-10-15 Boehringer Mannheim Gmbh Verfahren und reagens zur bestimmung der beta -lipoproteine
DE3009037A1 (de) * 1980-03-08 1981-09-24 Boehringer Mannheim Gmbh Verfahren zur direkten bestimmung des lipidgehaltes der (beta) -lipoproteine des blutes
DE3135814A1 (de) * 1981-09-10 1983-03-24 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven extrakorporalen praezipitation von low density lipoproteinen aus vollserum oder plasma
JPS58187859A (ja) * 1982-04-26 1983-11-02 Kyoto Daiichi Kagaku:Kk 血小板粘着能の測定方法
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
DE3330648C2 (de) * 1983-08-25 1986-11-20 Behringwerke Ag, 3550 Marburg Verfahren zum Abtrennen von Lipoproteinen mittels derivatisiertem Polyhydroxymethylen
NZ208241A (en) * 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
DE3422407A1 (de) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen Verwendung von heparinderivaten zur selektiven extrakorporalen praezipitation von low-density-lipoproteinen aus vollserum oder plasma
NZ213819A (en) * 1984-10-31 1988-05-30 Kanegafuchi Chemical Ind Lipoprotein adsorbent using hydroxy-containing polymer gel
FR2573997B1 (fr) * 1984-12-03 1986-12-26 Commissariat Energie Atomique Support solide capable d'adsorber des lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que le plasma sanguin
JPH0622626B2 (ja) * 1985-01-11 1994-03-30 鐘淵化学工業株式会社 体外循環治療用吸着体の再生方法
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
SE456136B (sv) * 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
FR2586359B1 (fr) * 1985-08-23 1989-09-08 Commissariat Energie Atomique Support solide a base d'alcool polyvinylique capable d'adsorber les lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que du plasma sanguin
JPH0725800B2 (ja) * 1987-04-10 1995-03-22 雪印乳業株式会社 硫酸エステル化物を用いて乳からラクトフエリンを分離、精製する方法
GB8728310D0 (en) * 1987-12-03 1988-01-06 St Georges Hosp Medical School Method of estimation of systemic cholesterol concentrations from capillary blood samples
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US5344571A (en) * 1992-02-18 1994-09-06 University Of Texas System Board Of Regents Method for separating isoanalytes and measuring analytes in fluids
WO1994007146A1 (en) * 1992-09-24 1994-03-31 Perseptive Biosystems, Inc. Quantitative measurement of ldl
JP4644948B2 (ja) * 2000-02-04 2011-03-09 東ソー株式会社 リポ蛋白質分析方法
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6582386B2 (en) 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US7022744B2 (en) * 2002-04-11 2006-04-04 Mitsubishi Chemical Corporation Ion exchanger for lipoproteins separation and lipoproteins separation method using the same
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562289A (en) * 1965-05-12 1971-02-09 Fmc Corp Chromatographic separation process by means of cellulose crystallite aggregates derivatives
US3573277A (en) * 1968-07-15 1971-03-30 Tasman Vaccine Labor Ltd Cellulosic ion exchange materials and method of making
US3838143A (en) * 1968-07-15 1974-09-24 Tasman Vaccine Labor Ltd Processes for the recovery of protein from waste effluents using regenerated cellulose ion-exchange resins
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates

Also Published As

Publication number Publication date
JPS52125396A (en) 1977-10-21
NZ180199A (en) 1978-11-13
GB1573512A (en) 1980-08-28
DE2708912C2 (de) 1986-10-16
SE447873B (sv) 1986-12-22
US4096136A (en) 1978-06-20
DE2708912A1 (de) 1977-09-08
FR2343251A1 (fr) 1977-09-30
AU2279777A (en) 1978-09-07
SE7702324L (sv) 1977-09-05
GB1543016A (en) 1979-03-28
FR2343251B3 (it) 1980-02-15
JPS6248193B2 (it) 1987-10-13

Similar Documents

Publication Publication Date Title
IT1115552B (it) Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno
IT1077260B (it) Procedimento per il controllo di apparecchi per l'analisi di gas
AR217087A1 (es) N-benzoil n'-piridiloxifenilureas y metodo de preparacion de las mismas
IT1082522B (it) Procedimento per la preparazione di tetraidofurano
DK164674C (da) Blodgas-kontrolvaeske
IT1080207B (it) Procedimento per la preparazione di benzotiazoli
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
AR227021A1 (es) Procedimiento de preparacion de concentrados de complejo protrombinico altamente purificado
IT1085033B (it) Procedimento per la preparazione di metossi-psorali
IT1091362B (it) Procedimento e dispositivo per la separazione di componenti desubli mabili da miscele di gas
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
NO150888C (no) Fremgangsmaate for fremstilling av et encelle-protein
NL185589C (nl) Bloedcoagulometer.
ES456483A0 (es) Procedimiento para la preparacion de compuestos de estilbeno.
RO77485A (ro) Procedeu pentru prepararea 1,2,3-tiadiazol-3-in-5-ilidenureelor
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
RO70629A (ro) Procedeu pentru prepararea 1,1-dioxidului de acid 3,4-dihidro-2-metil-4-oxo-2h-1,2-benzotiazin-3-carboxilic
SE414346B (sv) Anordning for bestemning av alkohohalten i blodet
IT1143732B (it) Procedimento per la preparazione di etinil-beta-ionolo
BE852157A (fr) Procede hydrometallurgique d'elaboration du zinc.
IT1088965B (it) Procedimento per la preparazione di eparina
NO143346C (no) Fremgangsmaate ved fremstilling av thymosin alfa1
ES491732A0 (es) Procedimiento de preparacion de monohidrato de 1,25-dihidro-xi-colecalciferol
IT1191052B (it) Reattivo per la determinazione delle beta-lipoproteine.